about
Metabolomics and Its Application to Acute Lung DiseasesClinical metabolomics: the next stage of clinical biochemistryGuidelines for the design, analysis and interpretation of 'omics' data: focus on human endometriumMass spectrometry-based proteomics for pre-eclampsia and preterm birthReview: Microfluidic applications in metabolomics and metabolic profilingTools and databases of the KOMICS web portal for preprocessing, mining, and dissemination of metabolomics data.Data-handling strategies for metabonomic studies: example of the UHPLC-ESI/ToF urinary signature of tetrahydrocannabinol in humans.Topologically inferring pathway activity toward precise cancer classification via integrating genomic and metabolomic data: prostate cancer as a case.Eating at the table of another: metabolomics of host-parasite interactions.Metabolomic Analysis of the Effect of Postnatal Hypoxia on the Retina in a Newly Born Piglet ModelMetabolonote: a wiki-based database for managing hierarchical metadata of metabolome analyses.The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnessesRecent advances of metabolomics in plant biotechnology.Changing metabolic signatures of amino acids and lipids during the prediabetic period in a pig model with impaired incretin function and reduced β-cell mass.Biomarkers intersect with the exposomeMetabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease.Signal intensities derived from different NMR probes and parameters contribute to variations in quantification of metabolites.Mass spectrometry-based holistic analytical approaches for metabolite profiling in systems biology studies.Immunological biomarkers of tuberculosis.Current trends and challenges in sample preparation for global metabolomics using liquid chromatography-mass spectrometry.Serum metabolomics as a novel diagnostic approach for disease: a systematic review.Pulmonary biomarkers in COPD exacerbations: a systematic review.Stability of energy metabolites-An often overlooked issue in metabolomics studies: A review.Identification of biomarkers for apoptosis in cancer cell lines using metabolomics: tools for individualized medicine.Metabolomics as a Driver in Advancing Precision Medicine in Sepsis.Comparative analysis of mass spectral similarity measures on peak alignment for comprehensive two-dimensional gas chromatography mass spectrometry.Electron Ionization-Induced Release of Coded Isotopic Reporter Ions in an m/z Zone of Minimal Interference for Quantifiable, Multiplexed GC-MS Analyses.Modern methodologies and tools for human hazard assessment of chemicalsPharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathyAutomated high through-put analysis of fractions generated during the isolation of natural products
P2860
Q26765930-18259344-B733-4326-A6AD-150EAEBBC40EQ26828034-D2420FF6-35FC-419D-AF32-AA92D9ADBDC1Q27012789-80284520-36E8-48F5-B44F-CB9C33D4DE37Q28083761-B1D244CA-C030-4328-8F24-451069D46953Q28392593-D265E5D4-BCF1-4CEA-A57D-07DB71781CCBQ30580477-5B64D445-842E-450E-A331-64CF7E59828DQ30658279-AC7D80CF-8A6F-42E6-9637-419A3A0B0DD0Q30988064-286C19D7-A95C-4388-B07A-D022304C4F59Q33671828-6642923D-91A9-4EFC-BB20-EAC67A2E3F16Q34792506-7B46D779-31B3-4F07-998C-951ACC9C9F49Q35297297-6EF6E25A-8E4E-45F3-B065-ABE19451F75BQ35527861-BCF561D7-BEA3-4802-9B9A-94E92D3DA5BAQ35683384-D1F35DD3-E7BA-4EDF-82B4-083B3E36FC71Q36109246-610A13CC-1CD5-4D1A-9601-65ECFCEFB6B0Q36607005-64DC0F4D-ABDD-4DD1-A02D-042D867B4217Q37191286-4CF24593-5678-4BEB-A4E3-E6E273E2CAFFQ37499674-DB53782C-1753-4BFF-86BB-9D0211E671E1Q37850751-E3E464C0-5F23-4247-A735-BB69E8FAB4A8Q37862987-3F9AD178-F491-4516-879C-0BBC257189CEQ38009236-C257373F-A114-4698-B204-3704FDA232E4Q38014695-BC59C06D-6667-45CA-A84D-E45C606A3F30Q38154291-EDC32B5B-BE3D-40D7-9C09-7335345B8EA9Q38469946-16343DB7-3054-4E96-A79D-D42134A6C939Q39078185-2DAE8B16-677B-40CD-ADA0-CF75E571067DQ39386206-D38143B7-635B-4796-9EEC-FEF94707B325Q41849865-12942C32-CD91-4972-9CA6-7B10479ACC78Q42914992-259568DB-90FC-40F2-8A34-9ABD55518C93Q47154406-BA4C3F85-3E03-45B5-89C5-4DFC0775B444Q57135103-3D06A998-220B-4B23-90F8-4764B9934DBAQ59020980-65EBD1ED-340D-4963-87A0-A355275339D4
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
From differentiating metabolites to biomarkers.
@en
From differentiating metabolites to biomarkers.
@nl
type
label
From differentiating metabolites to biomarkers.
@en
From differentiating metabolites to biomarkers.
@nl
prefLabel
From differentiating metabolites to biomarkers.
@en
From differentiating metabolites to biomarkers.
@nl
P2860
P1476
From differentiating metabolites to biomarkers.
@en
P2093
Geoffrey A Lane
Scott J Harrison
P2860
P2888
P304
P356
10.1007/S00216-009-2690-3
P407
P577
2009-03-11T00:00:00Z
2009-06-01T00:00:00Z